BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vélez-Santamaría V, Verdura E, Macmurdo C, Planas-Serra L, Schlüter A, Casas J, Martínez JJ, Casasnovas C, Si Y, Thompson SS, Maroofian R, Pujol A. Expanding the clinical and genetic spectrum of PCYT2-related disorders. Brain 2020;143:e76. [PMID: 32889549 DOI: 10.1093/brain/awaa229] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Wei Q, Luo WJ, Yu H, Wang PS, Dong HL, Li HF, Wu ZY. A novel PCYT2 mutation identified in a Chinese consanguineous family with hereditary spastic paraplegia. J Genet Genomics 2021:S1673-8527(21)00192-2. [PMID: 34384721 DOI: 10.1016/j.jgg.2021.06.008] [Reference Citation Analysis]
2 Kaiyrzhanov R, Wortmann S, Reid T, Dehghani M, Vahidi Mehrjardi MY, Alhaddad B, Wagner M, Deschauer M, Cordts I, Fernandez-Murray JP, Treffer V, Metanat Z, Pitman A, Houlden H, Meitinger T, Carroll C, McMaster CR, Maroofian R. Defective phosphatidylethanolamine biosynthesis leads to a broad ataxia-spasticity spectrum. Brain 2021;144:e30. [PMID: 33454747 DOI: 10.1093/brain/awaa442] [Reference Citation Analysis]
3 Leonardis L, Skrjanec Pusenjak M, Maver A, Jaklic H, Ozura Brecko A, Koritnik B, Peterlin B, Writzl K. Axonal Polyneuropathy in 2 Brothers With a Homozygous Missense Variant in the First Catalytic Domain of PCYT2. Neurol Genet 2022;8:e658. [PMID: 35243002 DOI: 10.1212/NXG.0000000000000658] [Reference Citation Analysis]
4 Lange LM, Gonzalez-Latapi P, Rajalingam R, Tijssen MAJ, Ebrahimi-Fakhari D, Gabbert C, Ganos C, Ghosh R, Kumar KR, Lang AE, Rossi M, van der Veen S, van de Warrenburg B, Warner T, Lohmann K, Klein C, Marras C; on behalf of the Task Force on Genetic Nomenclature in Movement Disorders. Nomenclature of Genetic Movement Disorders: Recommendations of the International Parkinson and Movement Disorder Society Task Force - An Update. Mov Disord 2022. [PMID: 35481685 DOI: 10.1002/mds.28982] [Reference Citation Analysis]
5 Ferdinandusse S, McWalter K, Te Brinke H, IJlst L, Mooijer PM, Ruiter JPN, van Lint AEM, Pras-Raves M, Wever E, Millan F, Guillen Sacoto MJ, Begtrup A, Tarnopolsky M, Brady L, Ladda RL, Sell SL, Nowak CB, Douglas J, Tian C, Ulm E, Perlman S, Drack AV, Chong K, Martin N, Brault J, Brokamp E, Toro C, Gahl WA, Macnamara EF, Wolfe L, Waisfisz Q, Zwijnenburg PJG, Ziegler A, Barth M, Smith R, Ellingwood S, Gaebler-Spira D, Bakhtiari S, Kruer MC, van Kampen AHC, Wanders RJA, Waterham HR, Cassiman D, Vaz FM; Undiagnosed Diseases Network. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids. Genet Med 2021;23:740-50. [PMID: 33239752 DOI: 10.1038/s41436-020-01027-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]